Molecular Partners Ag Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 62.16%-880.70%-1,087.34%
EBIT Margin 61.50%-868.26%-1,231.73%
EBITDA Margin 61.50%-868.26%-1,231.73%
Operating Margin 61.50%-868.26%-1,231.73%
Net Margin 62.16%-880.70%-1,087.38%
FCF Margin -327.25%-937.61%61.91%-846.55%-1,206.30%
Efficiency
Assets Average 0.23M0.25M0.20M
Equity Average 0.23M0.25M0.20M
Invested Capital 0.19M0.27M0.22M0.18M
Asset Utilization Ratio 856.6432.0027.98
Leverage & Solvency
Interest Coverage Ratio 188.39-11.85-0.00M
Equity Ratio 1.001.001.001.00
Times Interest Earned 188.39-11.85-0.00M
Valuation
Enterprise Value -192.16M472.75M-45.65M-73.44M-12.26M
Market Capitalization 616.79M212.97M137.25M157.61M
Return Ratios
Return on Sales 0.62%-8.81%-10.87%
Return on Capital Employed -6.85%4.30%5.77%
Return on Assets 532.48%-281.86%-304.25%
Return on Equity 532.48%-281.86%-304.25%